Skip to content

A randomized crossover physician reader study of artificial intelligence-assisted intracranial aneurysm embolization planning

A Study of Deep Learning-Based Prediction of Intracranial Aneurysm Rupture Risk and Neurointerventional Embolization Planning

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129615
Enrollment
Unknown
Registered
2026-08-07
Start date
2026-08-07
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Aneurysm

Interventions

Internal retrospective independent test cohort:None
External Centre 1 retrospective independent test cohort:None
External Centre 2 retrospective independent test cohort:None
Internal silent prospective validation cohort:None
External Centre 1 silent prospective validation cohort:None
AI-first crossover reader group:Readers will complete procedural planning for all locked cases with artificial intelligence assistance during the first reading period. After a washout period of 28+/-3
Unaided-first crossover reader group:Readers will complete procedural planning for all locked cases without artificial intelligence assistance during the first reading period. After a washout period o

Sponsors

Medical Ethics Committee of the General Hospital of the Northern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Adults aged 18 years or older. 2.A confirmed diagnosis of intracranial aneurysm based on clinical and imaging examinations. 3.Availability of three-dimensional digital subtraction angiography data that meet the input and analytical requirements of the artificial intelligence system. 4.The rupture status of the target aneurysm at the current presentation can be reliably determined. 5.The patient has undergone or is scheduled to undergo coil embolization for the intracranial aneurysm. 6.Information regarding stent use and the specifications of the first framing coil is available from procedural planning or actual treatment records. 7.Clinical, imaging and procedural data can be reliably matched to the target aneurysm. 8.The collection and use of study data are covered by the scope of the relevant ethics approval. 9.For patients with multiple intracranial aneurysms, the target aneurysm for the current treatment can be prespecified before analysis or reader assessment.

Exclusion criteria

Exclusion criteria: 1.Digital subtraction angiography images contain severe artefacts, lack critical image sections, or cannot be reconstructed into a three-dimensional dataset that meets the study requirements. 2.The target aneurysm has previously undergone surgical or endovascular treatment resulting in substantial morphological alteration outside the prespecified study scope. 3.The target aneurysm cannot be reliably matched with its rupture status, clinical data or procedural records. 4.Key procedural information, including stent use or the diameter of the first framing coil, is missing and cannot be verified from the source records. 5.Critical imaging or clinical information required for the primary study tasks is unavailable. 6.The collection or use of the case data is outside the scope of the ethics approval, informed consent or applicable data-use requirements. 7.Any inclusion criterion is not fulfilled.

Design outcomes

Primary

MeasureTime frame
Concordance rate of stent-assistance recommendations with the expert reference standard;Proportion of recommended first framing-coil diameters within the expert-defined acceptable range;

Secondary

MeasureTime frame
Dice similarity coefficient for automated intracranial aneurysm segmentation;Area under the receiver operating characteristic curve for classification of intracranial aneurysm rupture status at presentation;

Countries

China

Contacts

Public ContactHai Jin

The General Hospital of Northern Theater Command

15524223807@163.com+86 24 2885 6577

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026